AKASA
akasa.com
AI platform for healthcare revenue cycle operations.
Quick Information
- Category:
- Healthcare
- Pricing:
- Contact Sales
- Platforms:
- Web, EHR integrations
- Free Plan:
- No
- Last Verified:
- October 2026
What Is AKASA?
AKASA is an AI platform for healthcare revenue cycle operations. It calls its approach Unified Automation and says it works inside a hospital's existing EHR and revenue cycle infrastructure to cut errors and improve efficiency. Third-party descriptions say the platform uses large language models to handle prior authorizations, claim status, denial management and coding support.
The company started as Alpha Health and announced a $60 million Series B in March 2021, led by BOND with Andreessen Horowitz and Costanoa Ventures. An aggregator reports a $120 million Series C on June 18, 2024, which would bring total funding to about $205 million, but no AKASA announcement of that round was found, so treat it as unconfirmed. Little customer outcome data turned up in the sources, so results such as denial reduction should be requested from the vendor. Pricing is not public.
AKASA suits hospitals and health systems with large revenue cycle teams that want to automate repetitive claims work. Compare Innovaccer, Cohere Health and Infinitus. Browse the Healthcare tools directory for more.
What Can You Use AKASA For?
Prior authorization
Automates authorization steps.
Claim status
Checks and follows up on claims.
Denial management
Helps work and resolve denials.
Coding support
Assists coding tasks.
AKASA Features
- Unified Automation — Automation inside existing EHR and revenue cycle systems.
- LLM-based workflows — Uses large language models for revenue cycle tasks.
- Claims and denials focus — Targets repetitive back-office work.
Who Is AKASA For?
- Health system revenue cycle teams — Reduce manual claims work.
- Hospital finance leaders — Improve efficiency and cash collection.
AKASA Pros & Limitations
What We Like
- Works within existing systems
- Focused on a clear problem area
- Well funded, per aggregators
Limitations
- Little public customer outcome data
- Series C details are from aggregators only
- No public pricing
AKASA Pricing
| Plan | Price | Main Features |
|---|---|---|
| Enterprise | Custom | Unified Automation for revenue cycle tasks |
Pricing was last verified October 2026. Check the official website for the latest pricing.
AI Listing Jungle Ranking
- Global Rank:
- #544
- Overall Score:
- 63.4/100
- Monthly Users:
- –
- Rank Change:
- ▼ 144
This ranking reflects AI Listing Jungle's own independent scoring methodology and is not an endorsement by AKASA or its company. How Our Rankings Work
Frequently Asked Questions
What does AKASA do?
It automates revenue cycle tasks such as prior authorization, claim status, denials and coding support.
What was AKASA's former name?
Alpha Health.
How much has it raised?
A $60M Series B in 2021, and an aggregator reports a $120M Series C in 2024 for about $205M total.
How much does it cost?
Pricing is not public.
Our Take
AKASA targets some of the most tedious work in healthcare finance, and working inside existing systems lowers rollout friction.
Ask for measured denial and productivity results from similar hospitals.
AKASA Alternatives
AKASA Comparisons
Ready to try AKASA?
Visit the official website to get started.
Visit Official WebsiteAI Listing Jungle is an independent AI tools directory. Product names, logos, and trademarks belong to their respective owners.